Non-randomised phase II trials of drug combinations
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference25 articles.
1. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J. Natl. Cancer Inst.,2000
2. Sylvester R, Van Glabbeke M, Collette L, et al. Statistical methodology of phase III cancer clinical trials: advances and future perspectives. Eur. J. Cancer 2002, 38, 162–168 (Suppl.).
3. Phase II Trials in the EORTC. Eur J Cancer 1997, 33, 1361–1363.
4. Laack E, Mende T, Dürk H, et al. Gemcitabine, vinorelbine, and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial. Eur J Cancer, 2002, 38, 652–658.
5. Taı̈eb J, Artru P, Baujat B, et al. Optimization of 5-FU/cisplatin combination with a new schedule of hydroxyurea, leucovorin, 5-fluorouracil and cisplatin (HLPF regimen) for metastatic oesophageal cancer. Eur J Cancer, 2002, 38, 659–664.
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008–2017;JNCI: Journal of the National Cancer Institute;2019-09-23
2. Sample size computation in phase II designs combining the A’Hern design and the Sargent and Goldberg design;Journal of Biopharmaceutical Statistics;2019-07-22
3. A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials;JNCI: Journal of the National Cancer Institute;2019-06-20
4. Phase II design: history and evolution;CHIN CLIN ONCOL;2014
5. Current clinical trials for advanced osteosarcoma and soft tissue sarcoma;Current Opinion in Oncology;2014-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3